(Q53098600)
Statements
Clinical and laboratory prognostic factors in patients with metastatic renal cell carcinoma treated with sunitinib and sorafenib after progression on cytokines. (English)
Alexandr Poprach
Tomas Pavlik
Bohuslav Melichar
Katerina Kubackova
Zbynek Bortlicek
Marek Svoboda
Radek Lakomy
Rostislav Vyzula
Igor Kiss
Czech Renal Cancer Cooperative Group
8 December 2013
32
4
488-495
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference